Metabolism and inflammation: implications for traumatic brain injury therapeutics

References

• Hyder AA, Wunderlich CA, Puvanachandra P, et al. The impact of traumatic brain injuries: a global perspective. NeuroRehabilitation. 2007;22(5):341–353.
   Google Scholar
• Rubiano AM, Carney N, Chesnut R, et al. Global neurotrauma research challenges and opportunities. Nature. 2015;527(7578):S193–197.
   PubMed Web of Science ®Google Scholar
• Dewan MC, Rattani A, Gupta S, et al. Estimating the global incidence of traumatic brain injury. J Neurosurg. 2018;1–18.
   Web of Science ®Google Scholar
• Stein DG. Embracing failure: what the Phase III progesterone studies can teach about TBI clinical trials. Brain Inj. 2015;29(11):1259–1272.
   PubMed Web of Science ®Google Scholar
• Howard RB, Sayeed I, Stein DG. Suboptimal dosing parameters as possible factors in the negative phase III clinical trials of progesterone for traumatic brain injury. J Neurotrauma. 2017;34(11):1915–1918.
   PubMed Web of Science ®Google Scholar
• McKee AC, Cantu RC, Nowinski CJ, et al. Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol. 2009;68(7):709–735.
   PubMed Web of Science ®Google Scholar
• McKee AC, Daneshvar DH. The neuropathology of traumatic brain injury. Handb Clin Neurol. 2015;127:45–66.
   PubMedGoogle Scholar
• Smith DH, Johnson VE, Stewart W. Chronic neuropathologies of single and repetitive TBI: substrates of dementia? Nat Rev Neurol. 2013;9(4):211–221.
   PubMed Web of Science ®Google Scholar
• Miñambres E, Cemborain A, Sánchez-Velasco P,et al. Correlation between transcranial interleukin-6 gradient and outcome in patients with acute brain injury. Crit Care Med. 2003; 31(3):933-938.
   Google Scholar
• Selwyn R, Hockenbury N, Jaiswal S, et al. Mild traumatic brain injury results in depressed cerebral glucose uptake: an 18FDG PET study. J Neurotrauma. 2013;30(23):1943–1953.
   PubMed Web of Science ®Google Scholar
• Helmy A, Carpenter KL, Menon DK, et al. The cytokine response to human traumatic brain injury: temporal profiles and evidence for cerebral parenchymal production. J Cereb Blood Flow Metab. 2011;31(2):658–670.
   PubMed Web of Science ®Google Scholar
• Ramlackhansingh AF, Brooks DJ, Greenwood RJ, et al. Inflammation after trauma: microglial activation and traumatic brain injury. Ann Neurol. 2011;70(3):374–383.
   PubMed Web of Science ®Google Scholar
• Balan IS, Saladino AJ, Aarabi B, et al. Cellular alterations in human traumatic brain injury: changes in mitochondrial morphology reflect regional levels of injury severity. J Neurotrauma. 2013;30(5):367–381.
   PubMed Web of Science ®Google Scholar
• Nordstrom CH, Nielsen TH, Schalen W, et al. Biochemical indications of cerebral ischaemia and mitochondrial dysfunction in severe brain trauma analysed with regard to type of lesion. Acta Neurochir (Wien). 2016;158(7):1231–1240.
   PubMed Web of Science ®Google Scholar
• Timofeev I, Carpenter KL, Nortje J, et al. Cerebral extracellular chemistry and outcome following traumatic brain injury: a microdialysis study of 223 patients. Brain. 2011;134(Pt 2):484–494.
   PubMedGoogle Scholar
• Peruzzotti-Jametti L, Pluchino S. Targeting mitochondrial metabolism in neuroinflammation: towards a therapy for progressive multiple sclerosis. Trends Mol Med. 2018;24(10):838–855.
   PubMed Web of Science ®Google Scholar
• Sliter DA, Martinez J, Hao L, et al. Parkin and PINK1 mitigate STING-induced inflammation. Nature. 2018;561:258–262.
   PubMed Web of Science ®Google Scholar
• Yin F, Sancheti H, Patil I, et al. Energy metabolism and inflammation in brain aging and Alzheimer’s disease. Free Radic Biol Med. 2016;100:108–122.
   PubMed Web of Science ®Google Scholar
• De Felice F, Lourenco M. Brain metabolic stress and neuroinflammation at the basis of cognitive impairment in Alzheimer’s disease. Front Aging Neurosci. 2015;7:94.
   PubMed Web of Science ®Google Scholar
• Appel SH, Zhao W, Beers DR, et al. The microglial-motoneuron dialogue in ALS. Acta Myol. 2011;30(1):4–8.
   PubMedGoogle Scholar
• Ganeshan K, Chawla A. Metabolic regulation of immune responses. Annu Rev Immunol. 2014;32:609–634.
   PubMed Web of Science ®Google Scholar
• Lodish HBA, Zipursky SL, Matsudaira P, et al. Molecular cell biology. New York: W. H. Freeman; 2000.
   Google Scholar
• Berg JM, Tymoczko JL. Biochemistry. New York: W.H. Freeman; 2002.
   Google Scholar
• Pellerin L, Pellegri G, Bittar PG, et al. Evidence supporting the existence of an activity-dependent astrocyte-neuron lactate shuttle. Dev Neurosci. 1998;20(4–5):291–299.
   PubMed Web of Science ®Google Scholar
• Pellerin L, Magistretti PJ. Sweet sixteen for ANLS. J Cereb Blood Flow and Metab. 2012;32(7):1152–1166.
   PubMed Web of Science ®Google Scholar
• Magistretti Pierre J, Allaman I. A cellular perspective on brain energy metabolism and functional imaging. Neuron. 2015;86(4):883–901.
   PubMed Web of Science ®Google Scholar
• Jalloh I, Helmy A, Howe DJ, et al. A comparison of oxidative lactate metabolism in traumatically injured brain and control brain. J Neurotrauma. 2018;35(17):2025–2035.
   PubMed Web of Science ®Google Scholar
• Mächler P, Wyss Matthias T, Elsayed M, et al. In vivo evidence for a lactate gradient from astrocytes to neurons. Cell Metab. 2016;23(1):94–102.
   PubMed Web of Science ®Google Scholar
• Waagepetersen HS, Bakken IJ, Larsson OM, et al. Comparison of lactate and glucose metabolism in cultured neocortical neurons and astrocytes using 13c-nmr spectroscopy. Dev Neurosci. 1998;20(4–5):310–320.
   PubMed Web of Science ®Google Scholar
• Boumezbeur F, Petersen KF, Cline GW, et al. the contribution of blood lactate to brain energy metabolism in humans measured by dynamic (13)c nuclear magnetic resonance spectroscopy. J Neurosci. 2010;30(42):13983–13991.
   PubMed Web of Science ®Google Scholar
• Patel AB, Lai JCK, Chowdhury GMI, et al. Direct evidence for activity-dependent glucose phosphorylation in neurons with implications for the astrocyte-to-neuron lactate shuttle. Proc Nat Acad Sci. 2014;111(14):5385.
   PubMed Web of Science ®Google Scholar
• Carpenter KL, Jalloh I, Gallagher CN, et al. (13)C-labelled microdialysis studies of cerebral metabolism in TBI patients. Eur J Pharm Sci. 2014;57:87–97.
   PubMed Web of Science ®Google Scholar
• Sarrafzadeh AS, Kiening KL, Callsen TA, et al. Metabolic changes during impending and manifest cerebral hypoxia in traumatic brain injury. Br J Neurosurg. 2003;17(4):340–346.
   PubMed Web of Science ®Google Scholar
• Jalloh I, Carpenter KLH, Grice P, et al. Glycolysis and the pentose phosphate pathway after human traumatic brain injury: microdialysis studies using 1,2-(13)C(2) glucose. J Cereb Blood Flow Metab. 2015;35(1):111–120.
   PubMed Web of Science ®Google Scholar
• Di Pietro V, Lazzarino G, Amorini AM, et al. Fusion or fission: the destiny of mitochondria in traumatic brain injury of different severities. Sci Rep. 2017;7(1):9189.
   PubMedGoogle Scholar
• Cheng G, Kong R-H, Zhang L-M, et al. Mitochondria in traumatic brain injury and mitochondrial-targeted multipotential therapeutic strategies. Br J Pharmacol. 2012;167(4):699–719.
   PubMed Web of Science ®Google Scholar
• Swerdlow RH, Parks JK, Miller SW, et al. Origin and functional consequences of the complex I defect in Parkinson’s disease. Ann Neurol. 1996;40(4):663–671.
   PubMed Web of Science ®Google Scholar
• Lazzarino G, Amorini AM, Petzold A, et al. Serum compounds of energy metabolism impairment are related to disability, disease course and neuroimaging in multiple sclerosis. Mol Neurobiol. 2017;54(9):7520–7533.
   PubMed Web of Science ®Google Scholar
• Bowling AC, Schulz JB, Brown RH Jr., et al. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem. 1993;61(6):2322–2325.
   PubMed Web of Science ®Google Scholar
• Davey GP, Peuchen S, Clark JB. Energy thresholds in brain mitochondria: potential involvement in neurodegeneration. J Biol Chem. 1998;273(21):12753–12757.
   PubMed Web of Science ®Google Scholar
• Petrosillo G, Matera M, Moro N, et al. Mitochondrial complex I dysfunction in rat heart with aging: critical role of reactive oxygen species and cardiolipin. Free Radic Biol Med. 2009;46(1):88–94.
   PubMed Web of Science ®Google Scholar
• Ventura B, Genova ML, Bovina C, et al. Control of oxidative phosphorylation by Complex I in rat liver mitochondria: implications for aging. Biochim Biophys Acta Bioenerg. 2002;1553(3):249–260.
   Web of Science ®Google Scholar
• Fang EF, Scheibye-Knudsen M, Chua KF, et al. Nuclear DNA damage signalling to mitochondria in ageing. Nat Rev Mol Cell Biol. 2016;17:308.
   PubMed Web of Science ®Google Scholar
• Carpenter KL, Jalloh I, Hutchinson PJ. Glycolysis and the significance of lactate in traumatic brain injury. Front Neurosci. 2015;9:112.
   PubMed Web of Science ®Google Scholar
• Liesz A, Dalpke A, Mracsko E, et al. DAMP signaling is a key pathway inducing immune modulation after brain injury. J Neurosci. 2015;35(2):583.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Raoof M, Chen Y, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464:104.
   PubMed Web of Science ®Google Scholar
• Lenzlinger PM, Morganti-Kossmann M-C, Laurer HL, et al. The duality of the inflammatory response to traumatic brain injury. Mol Neurobiol. 2001;24(1):169–181.
   PubMed Web of Science ®Google Scholar
• Hinson HE, Rowell S, Schreiber M. Clinical evidence of inflammation driving secondary brain injury: A systematic review. J Trauma Acute Care Surg. 2015;78:1.
   PubMed Web of Science ®Google Scholar
• Johnson VE, Stewart JE, Begbie FD, et al. Inflammation and white matter degeneration persist for years after a single traumatic brain injury. Brain. 2013;136(1):28–42.
   PubMed Web of Science ®Google Scholar
• Helmy A, Guilfoyle MR, Carpenter KL, et al. Recombinant human interleukin-1 receptor antagonist in severe traumatic brain injury: a phase II randomized control trial. J Cereb Blood Flow Metab. 2014;34(5):845–851.
   PubMed Web of Science ®Google Scholar
• Thelin EP, Tajsic T, Zeiler FA, et al. Monitoring the neuroinflammatory response following acute brain injury. Front Neurol. 2017;8:351.
   PubMed Web of Science ®Google Scholar
• Bellander B-M, Singhrao SK, Ohlsson M, et al. Complement activation in the human brain after traumatic head injury. J Neurotrauma. 2001;18(12):1295–1311.
   PubMed Web of Science ®Google Scholar
• Schäfer MKH, Schwaeble WJ, Post C, et al. Complement C1q is dramatically up-regulated in brain microglia in response to transient global cerebral ischemia. J Immunol. 2000;164(10):5446.
   PubMed Web of Science ®Google Scholar
• Hammad A, Westacott L, Zaben M. The role of the complement system in traumatic brain injury: a review. J Neuroinflammation. 2018;15(1):24.
   PubMedGoogle Scholar
• Vink R, Gabrielian L, Thornton E. The role of substance p in secondary pathophysiology after traumatic brain injury. Front Neurol. 2017;8:304.
   PubMed Web of Science ®Google Scholar
• Tanaka R, Komine-Kobayashi M, Mochizuki H, et al. Migration of enhanced green fluorescent protein expressing bone marrow-derived microglia/macrophage into the mouse brain following permanent focal ischemia. Neuroscience. 2003;117(3):531–539.
   PubMed Web of Science ®Google Scholar
• Schilling M, Besselmann M, Müller M, et al. Predominant phagocytic activity of resident microglia over hematogenous macrophages following transient focal cerebral ischemia: an investigation using green fluorescent protein transgenic bone marrow chimeric mice. Exp Neurol. 2005;196(2):290–297.
   PubMed Web of Science ®Google Scholar
• Adam D, Rishma V, Jianghua F, et al. Proliferating resident microglia after focal cerebral ischaemia in mice. J Cereb Blood Flow Metab. 2007;27(12):1941–1953.
   PubMed Web of Science ®Google Scholar
• Herisson F, Frodermann V, Courties G, et al. Direct vascular channels connect skull bone marrow and the brain surface enabling myeloid cell migration. Nat Neurosci. 2018;21(9):1209–1217.
   PubMed Web of Science ®Google Scholar
• Csuka E, Morganti-Kossmann MC, Lenzlinger PM, et al. IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-α, TGF-β1 and blood–brain barrier function. J Neuroimmunol. 1999;101(2):211–221.
   PubMed Web of Science ®Google Scholar
• Semple BD, Bye N, Ziebell JM, et al. Deficiency of the chemokine receptor CXCR2 attenuates neutrophil infiltration and cortical damage following closed head injury. Neurobiol Dis. 2010;40(2):394–403.
   PubMed Web of Science ®Google Scholar
• Farooqui AA, Horrocks LA, Farooqui T. Modulation of inflammation in brain: a matter of fat. J Neurochem. 2007;101(3):577–599.
   PubMed Web of Science ®Google Scholar
• Ziebell JM, Morganti-Kossmann MC. Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics. 2010;7(1):22–30.
   PubMed Web of Science ®Google Scholar
• Becher B, Spath S, Goverman J. Cytokine networks in neuroinflammation. Nat Rev Immunol. 2017;17(1):49–59.
   PubMed Web of Science ®Google Scholar
• Cantaert T, Baeten D, Tak PP, et al. Type I IFN and TNFα cross-regulation in immune-mediated inflammatory disease: basic concepts and clinical relevance. Arthritis Res Ther. 2010;12(5):219.
   PubMed Web of Science ®Google Scholar
• Salim T, Sershen CL, May EE. Investigating the role of TNF-α and IFN-γ activation on the dynamics of iNOS gene expression in LPS stimulated macrophages. PLOS ONE. 2016;11(6):e0153289.
   PubMed Web of Science ®Google Scholar
• Singhal A, Baker AJ, Hare GMT, et al. Association between cerebrospinal fluid interleukin-6 concentrations and outcome after severe human traumatic brain injury. J Neurotrauma. 2002;19(8):929–937.
   PubMed Web of Science ®Google Scholar
• Italiani P, Boraschi D. From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation. Front Immunol. 2014;5:514.
   PubMed Web of Science ®Google Scholar
• Ransohoff RM. A polarizing question: do M1 and M2 microglia exist? Nat Neurosci. 2016;19:987.
   PubMed Web of Science ®Google Scholar
• Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014;6:13.
   PubMedGoogle Scholar
• Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 2012;122(3):787–795.
   PubMed Web of Science ®Google Scholar
• Guillemin GJ, Brew BJ. Microglia, macrophages, perivascular macrophages, and pericytes: A review of function and identification. J Leukoc Biol. 2004;75(3):388–397.
   PubMed Web of Science ®Google Scholar
• Ford AL, Goodsall AL, Hickey WF, et al. Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared. J Immunol. 1995;154(9):4309.
   PubMed Web of Science ®Google Scholar
• Satoh J-I, Kino Y, Asahina N, et al. TMEM119 marks a subset of microglia in the human brain. Neuropathology. 2015;36(1):39–49.
   PubMed Web of Science ®Google Scholar
• Bennett ML, Bennett FC, Liddelow SA, et al. New tools for studying microglia in the mouse and human CNS. Proc Natl Acad Sci U S A. 2016;113(12):E1738–E1746.
   PubMed Web of Science ®Google Scholar
• Perry VH, Teeling J. Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration. Semin Immunopathol. 2013;35(5):601–612.
   PubMed Web of Science ®Google Scholar
• Trahanas DM, Cuda CM, Perlman H, et al. Differential activation of infiltrating monocyte-derived cells after mild and severe traumatic brain injury. Shock. 2015;43(3):255–260.
   PubMed Web of Science ®Google Scholar
• Girard S, Brough D, Lopez-Castejon G, et al. Microglia and macrophages differentially modulate cell death after brain injury caused by oxygen-glucose deprivation in organotypic brain slices. Glia. 2013;61(5):813–824.
   PubMed Web of Science ®Google Scholar
• Liddelow SA, Guttenplan KA, Clarke LE, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481–487.
   PubMed Web of Science ®Google Scholar
• Hovda DA, Gurkoff GG, Sofroniew MV, et al. Essential protective roles of reactive astrocytes in traumatic brain injury. Brain. 2006;129(10):2761–2772.
   PubMedGoogle Scholar
• Mierzwa AJ, Sullivan GM, Armstrong RC, et al. Components of myelin damage and repair in the progression of white matter pathology after mild traumatic brain injury. J Neuropathol Exp Neurol. 2015;74(3):218–232.
   PubMed Web of Science ®Google Scholar
• Armstrong RC, Mierzwa AJ, Marion CM, et al. White matter involvement after TBI: clues to axon and myelin repair capacity. Exp Neurol. 2016;275:328–333.
   PubMed Web of Science ®Google Scholar
• O’Neill LA, Pearce EJ. Immunometabolism governs dendritic cell and macrophage function. J Exp Med. 2016;213(1):15–23.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Prados JC, Traves PG, Cuenca J, et al. Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J Immunol. 2010;185(1):605–614.
   PubMed Web of Science ®Google Scholar
• Vats D, Mukundan L, Odegaard JI, et al. Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab. 2006;4(1):13–24.
   PubMed Web of Science ®Google Scholar
• Gao F, Chen D, Hu Q, et al. Rotenone directly induces BV2 cell activation via the p38 MAPK pathway. PLoS One. 2013;8(8):e72046.
   PubMed Web of Science ®Google Scholar
• Ye J, Jiang Z, Chen X, et al. Electron transport chain inhibitors induce microglia activation through enhancing mitochondrial reactive oxygen species production. Exp Cell Res. 2016;340(2):315–326.
   PubMed Web of Science ®Google Scholar
• Mount MP, Lira A, Grimes D, et al. Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons. J Neurosci. 2007;27(12):3328–3337.
   PubMed Web of Science ®Google Scholar
• Gao H-M, Hong J-S, Zhang W, et al. Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. J Neurosci. 2002;22:782–790.
   PubMed Web of Science ®Google Scholar
• Emmrich JV, Hornik TC, Neher JJ, et al. Rotenone induces neuronal death by microglial phagocytosis of neurons. FEBS J. 2013;280(20):5030–5038.
   PubMed Web of Science ®Google Scholar
• Sheng W, Zong Y, Mohammad A, et al. Pro-inflammatory cytokines and lipopolysaccharide induce changes in cell morphology, and upregulation of ERK1/2, iNOS and sPLA(2)-IIA expression in astrocytes and microglia. J Neuroinflammation. 2011;8:121.
   PubMed Web of Science ®Google Scholar
• Littlewood-Evans A, Sarret S, Apfel V, et al. GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis. J Exp Med. 2016;213(9):1655–1662.
   PubMed Web of Science ®Google Scholar
• Sheth SA, Iavarone AT, Liebeskind DS, et al. Targeted lipid profiling discovers plasma biomarkers of acute brain injury. PLoS One. 2015;10(6):e0129735.
   PubMed Web of Science ®Google Scholar
• Thelin EP, Zeiler FA, Ercole A, et al. Serial sampling of serum protein biomarkers for monitoring human traumatic brain injury dynamics: a systematic review. Front Neurol. 2017;8:300.
   PubMed Web of Science ®Google Scholar
• Roberts I, Yates D, Sandercock P, et al. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinicallysignificant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet. 2004; 364(9442):1321-1328.
   Google Scholar
• Wright DW, Yeatts SD, Silbergleit R, et al. Very early administration of progesterone for acute traumatic brain injury. N Engl J Med. 2014;371(26):2457–2466.
   PubMed Web of Science ®Google Scholar
• Skolnick BE, Maas AI, Narayan RK, et al. A clinical trial of progesterone for severe traumatic brain injury. N Engl J Med. 2014;371(26):2467–2476.
   PubMed Web of Science ®Google Scholar
• Zafonte RD, Bagiella E, Ansel BM, et al. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: citicoline brain injury treatment trial (cobrit). JAMA. 2012;308(19):1993–2000.
   PubMed Web of Science ®Google Scholar
• Temkin NR, Anderson GD, Winn HR, et al. Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial. Lancet Neurol. 2007;6(1):29–38.
   PubMed Web of Science ®Google Scholar
• Robertson CS, McCarthy JJ, Miller ER, et al. Phase II clinical trial of atorvastatin in mild traumatic brain injury. J Neurotrauma. 2016;34(7):1394–1401.
   Web of Science ®Google Scholar
• Ng SY, Semple BD, Morganti-Kossmann MC, et al. Attenuation of microglial activation with minocycline is not associated with changes in neurogenesis after focal traumatic brain injury in adult mice. J Neurotrauma. 2012;29(7):1410–1425.
   PubMed Web of Science ®Google Scholar
• Casha S, Zygun D, McGowan MD, et al. Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury. Brain. 2012;135(4):1224–1236.
   PubMed Web of Science ®Google Scholar
• Scott G, Zetterberg H, Jolly A, et al. Minocycline reduces chronic microglial activation after brain trauma but increases neurodegeneration. Brain. 2018;141(2):459–471.
   PubMedGoogle Scholar
• Zangbar B, Pandit V, Rhee P, et al. Clinical outcomes in patients on preinjury ibuprofen with traumatic brain injury. Am J Surg. 2015;209(6):921–926.
   PubMed Web of Science ®Google Scholar
• Browne KD, Iwata A, Putt ME, et al. Chronic ibuprofen administration worsens cognitive outcome following traumatic brain injury in rats. Exp Neurol. 2006;201(2):301–307.
   PubMed Web of Science ®Google Scholar
• Tobinick E, Kim NM, Reyzin G, et al. Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept. CNS Drugs. 2012;26(12):1051–1070.
   PubMed Web of Science ®Google Scholar
• Lu K-T, Wang Y-W, Yang J-T, et al. Effect of interleukin-1 on traumatic brain injury–induced damage to hippocampal neurons. J Neurotrauma. 2005;22(8):885–895.
   PubMed Web of Science ®Google Scholar
• Newell EA, Todd BP, Mahoney J, et al. Combined blockade of interleukin-1α and −1β signaling protects mice from cognitive dysfunction after traumatic brain injury. eNeuro. 2018;5(2):ENEURO.0385–0317.2018.
   PubMed Web of Science ®Google Scholar
• James G, Kayode O, Sharon H, et al. Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) study. J Neurosurg. 2018;128(2):515–523.
   PubMed Web of Science ®Google Scholar
• Hutchinson PJ, O’Connell MT, Rothwell NJ, et al. Inflammation in human brain injury: intracerebral concentrations of IL-1α, IL-1β, and their endogenous inhibitor IL-1ra. J Neurotrauma. 2007;24(10):1545–1557.
   PubMed Web of Science ®Google Scholar
• Helmy A, Guilfoyle MR, Carpenter KLH, et al. Recombinant human interleukin-1 receptor antagonist promotes M1 microglia biased cytokines and chemokines following human traumatic brain injury. J Cereb Blood Flow Metab. 2016;36(8):1434–1448.
   PubMed Web of Science ®Google Scholar
• Hellewell S, Semple BD, Morganti-Kossmann MC. Therapies negating neuroinflammation after brain trauma. Brain Res. 1640;36–56:2016.
   Google Scholar
• Bergold PJ. Treatment of traumatic brain injury with anti-inflammatory drugs. Exp Neurol. 2016;275:367–380.
   PubMed Web of Science ®Google Scholar
• Kumar A, Loane DJ. Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention. Brain Behav Immun. 2012;26(8):1191–1201.
   PubMed Web of Science ®Google Scholar
• Turner MD, Nedjai B, Hurst T, et al. Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta, Mol Cell Res. 2014;1843(11):2563–2582.
   PubMed Web of Science ®Google Scholar
• Gaba A, Grivennikov SI, Do MV, et al. Cutting edge: IL-10–mediated tristetraprolin induction is part of a feedback loop that controls macrophage STAT3 Activation and cytokine production. J Immunol. 2012;189:2089–2093.
   PubMed Web of Science ®Google Scholar
• Graham DB, Jasso GJ, Mok A, et al. nitric oxide engages an anti-inflammatory feedback loop mediated by peroxiredoxin 5 in phagocytes. Cell Rep. 2018;24(4):838–850.
   PubMed Web of Science ®Google Scholar
• Stovell MG, Mada MO, Carpenter TA, et al. Phosphorus spectroscopy in acute TBI demonstrates metabolic changes that relate to outcome in the presence of normal structural MRI. J Cereb Blood Flow Metab. 2018; Sep18:271678X18799176. doi: 10.1177/0271678X18799176. [Epub ahead of print].
   Google Scholar
• Oresic M, Posti JP, Kamstrup-Nielsen MH, et al. Human serum metabolites associate with severity and patient outcomes in traumatic brain injury. EBioMedicine. 2016;12:118–126.
   PubMed Web of Science ®Google Scholar
• Yi L, Shi S, Wang Y, et al. Serum metabolic profiling reveals altered metabolic pathways in patients with post-traumatic cognitive impairments. Sci Rep. 2016;6:21320.
   PubMed Web of Science ®Google Scholar
• Glenn TC, Hirt D, Mendez G, et al. Metabolomic analysis of cerebral spinal fluid from patients with severe brain injury. In: Katayama Y, Maeda T, Kuroiwa T editors. Brain Edema XV. Vienna: Springer Vienna; 2013. p. 115–119.
   Google Scholar
• Gallagher CN, Carpenter KLH, Grice P, et al. The human brain utilizes lactate via the tricarboxylic acid cycle: a 13C-labelled microdialysis and high-resolution nuclear magnetic resonance study. Brain. 2009;132(10):2839–2849.
   PubMedGoogle Scholar
• Jalloh I, Helmy A, Howe DJ, et al. Focally perfused succinate potentiates brain metabolism in head injury patients. J Cereb Blood Flow Metab. 2017;37(7):2626–2638.
   PubMed Web of Science ®Google Scholar
• Young B, Ott L, Dempsey R, et al. Relationship between admission hyperglycemia and neurologic outcome of severely brain-injured patients. Ann Surg. 1989;210(4):466–473.
   PubMed Web of Science ®Google Scholar
• Vespa PM, McArthur D, O’Phelan K, et al. Persistently low extracellular glucose correlates with poor outcome 6 months after human traumatic brain injury despite a lack of increased lactate: a microdialysis study. J Cereb Blood Flow Metab. 2003;23(7):865–877.
   PubMed Web of Science ®Google Scholar
• Meierhans R, Béchir M, Ludwig S, et al. Brain metabolism is significantly impaired at blood glucose below 6 mM and brain glucose below 1 mM in patients with severe traumatic brain injury. Crit Care. 2010;14(1):R13–R13.
   PubMed Web of Science ®Google Scholar
• Clayton TJ, Nelson RJ, Manara AR. Reduction in mortality from severe head injury following introduction of a protocol for intensive care management†‡. Br J Anaesth. 2004;93(6):761–767.
   PubMed Web of Science ®Google Scholar
• Hermanides J, Plummer MP, Finnis M, et al. Glycaemic control targets after traumatic brain injury: a systematic review and meta-analysis. Crit Care. 2018;22:11.
   PubMed Web of Science ®Google Scholar
• Vespa P, McArthur DL, Stein N, et al. Tight glycemic control increases metabolic distress in traumatic brain injury: A randomized controlled within-subjects trial*. Crit Care Med. 2012;40:6.
   Web of Science ®Google Scholar
• Plummer MP, Notkina N, Timofeev I, et al. Cerebral metabolic effects of strict versus conventional glycaemic targets following severe traumatic brain injury. Crit Care. 2018;22:16.
   PubMed Web of Science ®Google Scholar
• Tannahill GM, Curtis AM, Adamik J, et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature. 2013;496:238.
   PubMed Web of Science ®Google Scholar
• Giorgi-Coll S, Amaral AI, Hutchinson PJA, et al. Succinate supplementation improves metabolic performance of mixed glial cell cultures with mitochondrial dysfunction. Sci Rep. 2017;7(1):1003.
   PubMedGoogle Scholar
• Chouchani ET, Pell VR, Gaude E, et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 2014;515(7527):431–435.
   PubMed Web of Science ®Google Scholar
• Stovell MG, Mada MO, Helmy A, et al. The effect of succinate on brain NADH/NAD+ redox state and high energy phosphate metabolism in acute traumatic brain injury. Sci Rep. 2018;8(1):11140.
   PubMedGoogle Scholar
• Oguro H, Iijima K, Takahashi K, et al. Successful Treatment with Succinate in a Patient with MELAS. Int Med. 2004;43(5):427–431.
   PubMed Web of Science ®Google Scholar
• Mills EL, Kelly B, Logan A, et al. Repurposing mitochondria from ATP production to ROS generation drives a pro-inflammatory phenotype in macrophages that depends on succinate oxidation by complex II. Cell. 2016;167(2):457–470.e413.
   PubMed Web of Science ®Google Scholar
• Peruzzotti-Jametti L, Bernstock JD, Vicario N, et al. Macrophage-derived extracellular succinate licenses neural stem cells to suppress chronic neuroinflammation. Cell Stem Cell. 2018;22(3):355–368.e313.
   PubMed Web of Science ®Google Scholar
• Pellerin L, Magistretti PJ. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci U S A. 1994;91(22):10625–10629.
   PubMed Web of Science ®Google Scholar
• Prieto R, Tavazzi B, Taya K, et al. Brain energy depletion in a rodent model of diffuse traumatic brain injury is not prevented with administration of sodium lactate. Brain Res. 2011;1404:39–49.
   PubMed Web of Science ®Google Scholar
• Immke DC, McCleskey EW. Lactate enhances the acid-sensing Na+ channel on ischemia-sensing neurons. Nat Neurosci. 2001;4:869.
   PubMed Web of Science ®Google Scholar
• Margineanu MB, Mahmood H, Fiumelli H, et al. L-lactate regulates the expression of synaptic plasticity and neuroprotection genes in cortical neurons: a transcriptome analysis. Front Mol Neurosci. 2018;11:375.
   PubMed Web of Science ®Google Scholar
• Constant JS, Feng JJ, Zabel DD, et al. Lactate elicits vascular endothelial growth factor from macrophages: a possible alternative to hypoxia. Wound Repair Regener. 2000;8(5):353–360.
   PubMed Web of Science ®Google Scholar
• Diarmuid S, Andrew P, William AH, et al. Lactate: a preferred fuel for human brain metabolism in vivo. J Cereb Blood Flow Metab. 2003;23(6):658–664.
   PubMed Web of Science ®Google Scholar
• Oddo M, Levine JM, Frangos S, et al. Brain lactate metabolism in humans with subarachnoid hemorrhage. Stroke. 2012;43(5):1418.
   PubMed Web of Science ®Google Scholar
• Ichai C, Armando G, Orban J-C, et al. Sodium lactate versus mannitol in the treatment of intracranial hypertensive episodes in severe traumatic brain-injured patients. Intensive Care Med. 2009;35(3):471–479.
   PubMed Web of Science ®Google Scholar
• Quintard H, Patet C, Zerlauth J-B, et al. Improvement of neuroenergetics by hypertonic lactate therapy in patients with traumatic brain injury is dependent on baseline cerebral lactate/pyruvate ratio. J Neurotrauma. 2016;33(7):681–687.
   PubMed Web of Science ®Google Scholar
• Francony GFB, Falcon D, Canet C, et al. Equimolar doses of mannitol and hypertonic saline in the treatment of increased intracranial pressure. Crit Care Med. 2008;36(3):795–800.
   PubMed Web of Science ®Google Scholar
• Mashimo T, Pichumani K, Vemireddy V, et al. Acetate is a bioenergetic substrate for human glioblastoma and brain metastases. Cell. 2014;159(7):1603–1614.
   PubMed Web of Science ®Google Scholar
• Chen R, Xu M, Nagati JS, et al. The acetate/ACSS2 switch regulates HIF-2 stress signaling in the tumor cell microenvironment. PLOS ONE. 2015;10(2):e0116515.
   PubMed Web of Science ®Google Scholar
• Gao X, Lin S-H, Ren F, et al. Acetate functions as an epigenetic metabolite to promote lipid synthesis under hypoxia. Nat Commun. 2016;7:11960.
   PubMed Web of Science ®Google Scholar
• Sanchez WY, McGee SL, Connor T, et al. Dichloroacetate inhibits aerobic glycolysis in multiple myeloma cells and increases sensitivity to bortezomib. Br J Cancer. 2013;108(8):1624–1633.
   PubMed Web of Science ®Google Scholar
• James MO, Jahn SC, Zhong G, et al. Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1. Pharmacol Ther. 2017;170:166–180.
   PubMed Web of Science ®Google Scholar
• Schmidt MM, Rohwedder A, Dringen R. Effects of chlorinated acetates on the glutathione metabolism and on glycolysis of cultured astrocytes. Neurotox Res. 2011;19(4):628–637.
   PubMed Web of Science ®Google Scholar
• Dimlich RVW, Marangos PJ. Dichloroacetate attenuates neuronal damage in a gerbil model of brain ischemia. J Mol Neurosci. 1994;5(2):69–81.
   PubMed Web of Science ®Google Scholar
• Arun P, Ariyannur PS, Moffett JR, et al. Metabolic acetate therapy for the treatment of traumatic brain injury. J Neurotrauma. 2009;27(1):293–298.
   Web of Science ®Google Scholar
• Schug Zachary T, Peck B, Jones Dylan T, et al. Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress. Cancer Cell. 2015;27(1):57–71.
   PubMed Web of Science ®Google Scholar
• Richards RH, Vreman HJ, Zager P, et al. Acetate metabolism in normal human subjects. Am J Kidney Diseases. 1982;2(1):47–57.
   PubMed Web of Science ®Google Scholar
• Kaufmann P, Engelstad K, Wei Y, et al. Dichloroacetate causes toxic neuropathy in MELAS. Neurology. 2006;66(3):324.
   PubMed Web of Science ®Google Scholar
• Stacpoole PW, Henderson GN, Yan Z, et al. Pharmacokinetics, metabolism, and toxicology of dichloroacetate. Drug Metab Rev. 1998;30(3):499–539.
   PubMed Web of Science ®Google Scholar
• Fink MP. Ethyl pyruvate. Curr Opin Anesthesiol. 2008;21:2.
   Web of Science ®Google Scholar
• Margolis SA, Coxon B. Identification and quantitation of the impurities in sodium pyruvate. Anal Chem. 1986;58(12):2504–2510.
   Web of Science ®Google Scholar
• Shi H, Wang HL, Pu HJ, et al. Ethyl pyruvate protects against blood-brain barrier damage and improves long-term neurological outcomes in a rat model of traumatic brain injury. CNS Neurosci Ther. 2015;21(4):374-384.
   Web of Science ®Google Scholar
• Su X, Wang H, Zhu L, et al. Ethyl pyruvate ameliorates intracerebral hemorrhage-induced brain injury through anti-cell death and anti-inflammatory mechanisms. Neuroscience. 2013;245:99-108.
   Web of Science ®Google Scholar
• Moro N, Ghavim SS, Harris NG, et al. Pyruvate treatment attenuates cerebral metabolic depression and neuronal loss after traumatic experimental brain injury. Brain Res. 2016;1642:270-277.
   Web of Science ®Google Scholar
• Moro N, Sutton RL. Beneficial effects of sodium or ethyl pyruvate after traumatic brain injury in the rat. Exp Neurol. 2010;225(2):391-401.
   PubMed Web of Science ®Google Scholar
• Su X, Wang H, Zhao J, et al. Beneficial effects of ethyl pyruvate through inhibiting high-mobility group box 1 expression and TLR4/NFkB pathway after traumatic brain injury in the rat. Mediators Inflamm. 2011;2011:807142.
   PubMed Web of Science ®Google Scholar
• Wang X, Perez E, Liu R, et al. Pyruvate protects mitochondria from oxidative stress in human neuroblastoma SK-N-SH cells. Brain Res. 2007;1132(1):1–9.
   PubMed Web of Science ®Google Scholar
• Castro MA, Beltrán FA, Brauchi S, et al. A metabolic switch in brain: glucose and lactate metabolism modulation by ascorbic acid. J Neurochem. 2009;110(2):423–440.
   PubMed Web of Science ®Google Scholar
• Covarrubias-Pinto A, Acuña AI, Beltrán FA, et al. Old things new view: ascorbic acid protects the brain in neurodegenerative disorders. Int J Mol Sci. 2015;16(12):28194–28217.
   PubMed Web of Science ®Google Scholar
• Round JL, Mazmanian SK. The gut microbiome shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9(5):313–323.
   PubMed Web of Science ®Google Scholar
• Dopkins N, Nagarkatti PS, Nagarkatti M. The role of gut microbiome and associated metabolome in the regulation of neuroinflammation in multiple sclerosis and its implications in attenuating chronic inflammation in other inflammatory and autoimmune disorders. Immunology. 2018;154(2):178–185.
   PubMed Web of Science ®Google Scholar
• Sundman MH, Chen N-K, Subbian V, et al. The bidirectional gut-brain-microbiota axis as a potential nexus between traumatic brain injury, inflammation, and disease. Brain Behav Immun. 2017;66:31–44.
   PubMed Web of Science ®Google Scholar
• Waligora-Dupriet A-J, Lafleur S, Charrueau C, et al. Head injury profoundly affects gut microbiota homeostasis: results of a pilot study. Nutrition. 2018;45:104–107.
   PubMed Web of Science ®Google Scholar
• Mason S. Lactate shuttles in neuroenergetics-homeostasis, allostasis and beyond. Front Neurosci. 2017;11:43.
   PubMed Web of Science ®Google Scholar
• Landeghem FKHV, Weiss T, Oehmichen M, et al. Decreased expression of glutamate transporters in astrocytes after human traumatic brain injury. J Neurotrauma. 2006;23(10):1518–1528.
   PubMed Web of Science ®Google Scholar
• Cantu D, Walker K, Andresen L, et al. Traumatic Brain Injury Increases Cortical Glutamate Network Activity by Compromising GABAergic Control. Cereb Cortex. 2015;25(8):2306–2320.
   PubMed Web of Science ®Google Scholar
• Amorini AM, Lazzarino G, Di Pietro V, et al. Severity of experimental traumatic brain injury modulates changes in concentrations of cerebral free amino acids. J Cell Mol Med. 2017;21(3):530–542.
   PubMed Web of Science ®Google Scholar
• Guerriero RM, Giza CC, Rotenberg A. Glutamate and GABA imbalance following traumatic brain injury. Curr Neurol Neurosci Rep. 2015;15(5):27.
   PubMed Web of Science ®Google Scholar
• Vespa P, Tubi M, Claassen J, et al. Metabolic crisis occurs with seizures and periodic discharges after brain trauma. Ann Neurol. 2016;79(4):579–590.
   PubMed Web of Science ®Google Scholar
• Yi J-H, Hazell AS. Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury. Neurochem Int. 2006;48(5):394–403.
   PubMed Web of Science ®Google Scholar
• Barger SW, Goodwin ME, Porter MM, et al. Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation. J Neurochem. 2007;101(5):1205–1213.
   PubMed Web of Science ®Google Scholar
• Dai -S-S, Zhou Y-G, Li W, et al. Local glutamate level dictates adenosine A(2A) receptor regulation of neuroinflammation and traumatic brain injury. J Neurosci. 2010;30(16):5802–5810.
   PubMed Web of Science ®Google Scholar
• Harvey BK, Airavaara M, Hinzman J, et al. Targeted over-expression of glutamate transporter 1 (GLT-1) reduces ischemic brain injury in a rat model of stroke. PLOS ONE. 2011;6(8):e22135.
   PubMed Web of Science ®Google Scholar
• Signoretti S, Marmarou A, Tavazzi B, et al. The protective effect of cyclosporin a upon N-acetylaspartate and mitochondrial dysfunction following experimental diffuse traumatic brain injury. J Neurotrauma. 2004;21(9):1154–1167.
   PubMed Web of Science ®Google Scholar
• Karlsson M, Pukenas B, Chawla S, et al. Neuroprotective effects of cyclosporine in a porcine pre-clinical trial of focal traumatic brain injury. J Neurotrauma. 2019; 36:14–24.
   Google Scholar
• Mazzeo AT, Alves ÓL, Gilman CB, et al. Brain metabolic and hemodynamic effects of cyclosporin A after human severe traumatic brain injury: a microdialysis study. Acta Neurochir (Wien). 2008;150(10):1019.
   PubMed Web of Science ®Google Scholar
• Jimmi H, Bonnie R, Philip E, et al. Dosing and safety of cyclosporine in patients with severe brain injury. J Neurosurg. 2008;109(4):699–707.
   PubMed Web of Science ®Google Scholar
• Mazzeo AT, Brophy GM, Gilman CB, et al. Safety and tolerability of cyclosporin a in severe traumatic brain injury patients: results from a prospective randomized trial. J Neurotrauma. 2009;26(12):2195–2206.
   PubMed Web of Science ®Google Scholar
• Aminmansour B, Fard SA, Habibabadi MR, et al. The efficacy of cyclosporine-a on diffuse axonal injury after traumatic brain injury. Adv Biomed Res. 2014;3:35.
   PubMedGoogle Scholar